HOLLY BELL-JOYNER: Open Payments
NPI 1063757334 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 34 payments from 7 companies in 2025. Trend: 2023 $1,782 · 2024 $806 · 2025 $708
Food & beverage: $708
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 11 | $254 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $227 |
| GlaxoSmithKline, LLC. | 11 | $154 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| HARMONY BIOSCIENCES LLC | 1 | $20 |
| INOGEN, INC. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: Prolastin-C Liquid, GLASSIA, TRELEGY ELLIPTA, TEZSPIRE, WAKIX, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH, NUCALA, Sunosi.
Industry payments across FL — which companies pay providers there.
